aldertx.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot /
BingBot /
BaiduSpider /
YandexBot /
Meta Tags
Title Alder Therapeutics – Creating a novel cell therapy platform with best-in-class
Description Cell therapy has taken a long time to evolve. In cell therapy the main challenge is to find the optimal manufacturing process that delivers the best therapeutic cells every single time. The Alder Edge helps to optimize pluripotent stem cell
Keywords N/A
Server Information
WebSite aldertx faviconaldertx.com
Host IP 75.2.70.75
Location United States
Related Websites
Site Rank
More to Explore
aldertx.com Valuation
US$1,737
Last updated: 2023-05-19 12:14:19

aldertx.com has Semrush global rank of 0. aldertx.com has an estimated worth of US$ 1,737, based on its estimated Ads revenue. aldertx.com receives approximately 200 unique visitors each day. Its web server is located in United States, with IP address 75.2.70.75. According to SiteAdvisor, aldertx.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$1,737
Daily Ads Revenue US$1
Monthly Ads Revenue US$48
Yearly Ads Revenue US$577
Daily Unique Visitors 13
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
aldertx.com. A 3600 IP: 75.2.70.75
aldertx.com. A 3600 IP: 99.83.190.102
aldertx.com. NS 14400 NS Record: ns02.one.com.
aldertx.com. NS 14400 NS Record: ns01.one.com.
aldertx.com. MX 3600 MX Record: 0 aldertx-com.mail.protection.outlook.com.
aldertx.com. TXT 3600 TXT Record: v=spf1 include:spf.protection.outlook.com -all
aldertx.com. TXT 3600 TXT Record: proxy.ssl-webflow.com
HtmlToTextCheckTime:2023-05-19 12:14:19
Alder Therapeutics The next era Our team Become a parter Creating a novel cell therapy platform with best-in-class processes The evolution of cell therapy Enter your contact information and we will get back to you and tell more. 17 TH OF JANUARY 2023 ALDER THERAPEUTICS LICENSES TWO CELL THERAPY PROGRAMS FROM DUKE-NUS AND BIOLAMINA 17 th January 2023, Stockholm, Sweden. In two separate exclusive license agreements, Alder Therapeutics AB secured access to Intellectual Property and know-how for two state-of-the-art methods to manufacture retinal and cardiac cell therapeutic products. Read the whole pressrelease here (PDF) 27 TH OF SEPTEMBER 2022 ALDER THERAPEUTICS SECURES 20 MSEK SEED FUNDING Alder Therapeutics secured 20 MSEK seed financing from two top tier Swedish life-science investors Flerie Invest AB and Linc AB (publ). Upon reaching certain development milestones, Alder will receive an additional 14.4 MSEK . The proceeds will be used to develop two of Alder’s initial stem cell
HTTP Headers
HTTP/1.1 301 Moved Permanently
Server: openresty
Date: Wed, 05 Oct 2022 09:03:00 GMT
Content-Type: text/html
Content-Length: 166
Connection: keep-alive
Location: https://aldertx.com/

HTTP/2 301 
server: openresty
date: Wed, 05 Oct 2022 09:03:00 GMT
content-type: text/html
content-length: 166
location: https://www.aldertx.com/

HTTP/2 200 
server: openresty
date: Wed, 05 Oct 2022 09:03:01 GMT
content-type: text/html
content-length: 18690
via: 1.1 varnish, 1.1 varnish
accept-ranges: bytes
age: 0
x-served-by: cache-iad-kcgs7200143-IAD, cache-dub4337-DUB
x-cache: MISS, MISS
x-cache-hits: 0, 0
x-timer: S1664960581.272033,VS0,VE258
vary: x-wf-forwarded-proto, Accept-Encoding
x-cluster-name: eu-west-1-prod-edge-blue
aldertx.com Whois Information
Domain Name: ALDERTX.COM
Registry Domain ID: 2605530288_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.one.com
Registrar URL: http://www.one.com
Updated Date: 2022-03-18T10:14:43Z
Creation Date: 2021-04-16T12:21:42Z
Registry Expiry Date: 2023-04-16T12:21:42Z
Registrar: One.com A/S
Registrar IANA ID: 1462
Registrar Abuse Contact Email: abuse@one.com
Registrar Abuse Contact Phone: +45 44451220
Domain Status: ok https://icann.org/epp#ok
Name Server: NS01.ONE.COM
Name Server: NS02.ONE.COM
DNSSEC: signedDelegation
DNSSEC DS Data: 13278 13 2 6780B3475558BC5EAC7EC372DF46B90F034C7AAAD99F27FAA0A9B782B3AEE80E
>>> Last update of whois database: 2022-10-05T09:08:29Z <<<